Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Neil Kumar

Affiliations

  • Ceo And President at Bridgebio Pharma Inc. (BBIO), 2020-07-06
  • Chief Executive Officer at Eidos Therapeutics Inc. (EIDX), 2019-07-09
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
EIDX $29.90 882,353 Large Shareholder, Officer, Director 24,575,501 2019-07-03 Filing
EIDX $25.93 1,103,848 Large Shareholder, Officer, Director 23,693,148 2019-05-24 Filing
EIDX $13.96 2,664 Large Shareholder, Officer, Director 22,589,300 2018-12-10 Filing
EIDX $13.29 37,989 Large Shareholder, Officer, Director 22,586,636 2018-12-10 Filing
EIDX $14.36 4,860 Large Shareholder, Officer, Director 22,548,647 2018-12-07 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
BBIO $30.22 56,445 Officer, Director 2,165,372 2020-07-02 Filing
BBIO $32.42 2,700 Officer, Director 2,221,817 2020-07-01 Filing
BBIO $31.67 33,700 Officer, Director 2,224,517 2020-07-01 Filing
BBIO $30.63 50,625 Officer, Director 2,258,217 2020-07-01 Filing
BBIO $30.01 10,600 Officer, Director 2,308,842 2020-06-08 Filing